Shaul, Chanan
Blotnick, Simcha
Adar, Liat
Muszkat, Mordechai
Bialer, Meir http://orcid.org/0000-0003-2046-4171
Caraco, Yoseph
Article History
Accepted: 4 May 2022
First Online: 14 June 2022
Declarations
:
: This work was not supported by any funding source.
: HS, SB, LA, MM, and YC do not have any conflicts of interest to disclose. MB received consultancy fees from Boehringer Ingelheim, Medison, Pharma 2B, Rekah-Vitamned, and Xenon Pharmaceuticals.
: The study protocols were approved by the Hadassah Institutional Review Board.
: Following a detailed explanation, all participants gave their written consent to participate in the study.
: Not applicable.
: Not applicable.
: Not applicable.
: CS, YC, and MB wrote the manuscript, LA, MB, and YC designed the research, CS and LA performed the research, and CS, SB, and LA analyzed the data.